Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Boehringer Ingelheim
Deloitte
Healthtrust
Fish and Richardson
Mallinckrodt
QuintilesIMS
McKinsey

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088169

« Back to Dashboard

NDA 088169 describes FLUOCINOLONE ACETONIDE, which is a drug marketed by Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs, Perrigo New York, Pharmaderm, Pharmafair, Taro, Usl Pharma, Akorn, Identi Pharms Inc, Lyne, Perrigo Israel, Actavis Labs Ut Inc, Bausch And Lomb, G And W Labs Inc, Gavis Pharms Llc, Glasshouse Pharms, and Morton Grove, and is included in forty-seven NDAs. It is available from fourteen suppliers. Additional details are available on the FLUOCINOLONE ACETONIDE profile page.

The generic ingredient in FLUOCINOLONE ACETONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 088169
Pharmacology for NDA: 088169
Medical Subject Heading (MeSH) Categories for 088169
Suppliers and Packaging for NDA: 088169
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUOCINOLONE ACETONIDE fluocinolone acetonide CREAM;TOPICAL 088169 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0060 N 0168-0060-15
FLUOCINOLONE ACETONIDE fluocinolone acetonide CREAM;TOPICAL 088169 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0060 N 0168-0060-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.025%
Approval Date:Dec 16, 1982TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
UBS
US Department of Justice
Boehringer Ingelheim
Citi
McKesson
Queensland Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.